Drug Sponsors

NeuroPhage raises $6.4M in additional financing

Monday, May 6, 2013 02:40 PM

NeuroPhage Pharmaceuticals, a company developing breakthrough therapies for neurodegenerative diseases, has raised $6.4 million in a private equity financing round. Mérieux Développement led the financing with participation from all current Neurophage investors, including Shire.  

More... »

AltheRx raises $15M, names Jim Bennethum CEO, appoints new board of directors

Monday, May 6, 2013 10:41 AM

AltheRx Pharmaceuticals, a privately-held clinical development company, announced a restructuring that includes a $15 million financing, the appointment of Jim Bennethum as CEO, and the appointment of a new board of directors.

More... »

Natera completes $54.6M financing for global rollout of Panorama prenatal test

Wednesday, May 1, 2013 02:46 PM

Natera, a genetic testing company, has completed a $54.6 million financing round to support the expansion and continued global rollout of Natera's non-invasive prenatal test, Panorama. The financing round included two new lead investors, OrbiMed Advisors and Harmony Partners, as well as other undisclosed new investors. All existing investors participated, including Claremont Creek Ventures, Lightspeed Venture Partners, Founders Fund and Sequoia Capital.

More... »

Aerocrine completes $50M debt and equity financing

Wednesday, May 1, 2013 10:58 AM

Aerocrine, a medical products company, has completed a financing with an affiliate of the U.S. investment firm OrbiMed Advisors and with Novo consisting of $35 million of debt. Aerocrine also raised $ 15 million of equity from OrbiMed and a number of institutional investors through a directed share issue.

More... »

Bayer to acquire Conceptus

Monday, April 29, 2013 10:50 AM

Bayer HealthCare has signed a merger agreement with Conceptus, a Mountain View, Calif.-based developer of the Essure procedure, a non-surgical permanent birth control method.

More... »

Eisai to establish new parenteral facility in China

Friday, April 26, 2013 12:28 PM

Eisai, a Japanese pharmaceutical company, has decided to establish a new parenteral facility on a lot retained by Eisai's Chinese subsidiary, Eisai China, at the Suzhou Industrial Park in Suzhou, China. 

More... »

OPKO Health to acquire Prolor Biotech

Wednesday, April 24, 2013 10:43 AM

OPKO Health, a multinational biopharmaceutical and diagnostics company, has signed a definitive merger agreement to acquire Prolor Biotech, a biopharmaceutical company focused on developing and commercializing longer-acting proprietary versions of already approved therapeutic proteins, in an all-stock transaction. 

More... »

Auris Medical secures $50M Series C financing for inner ear

Wednesday, April 17, 2013 10:15 AM

Auris Medical, a Swiss biotechnology company focused on novel therapeutics for the treatment of inner ear disorders, has completed a $50 million Series C financing. Two leading venture capital firms, Sofinnova Ventures  of Menlo Park, Calif., and Sofinnova Partners of Paris, participated in the financing.

More... »

Merck opens new manufacturing facility in Hangzhou, China

Tuesday, April 16, 2013 02:05 PM

Global healthcare company Merck has opened its new pharmaceutical manufacturing facility in Hangzhou, China. The facility, located in the Hangzhou Economic and Technology Area (HEDA), will package Merck medicines for China and the Asia Pacific region and will become a critical part of Merck's global supply chain. 

More... »

Thermo Fisher Scientific to acquire Life Technologies

Tuesday, April 16, 2013 11:29 AM

Thermo Fisher Scientific, a healthcare equipment company, has signed a definitive agreement to acquire Life Technologies, a global biotechnology tools company, for $76.00 in cash per fully diluted common share, or approximately $13.6 billion, plus the assumption of net debt at close ($2.2 billion as of year end 2012).

More... »